BioMarin Pharmaceutical Inc.
BMRN
$58.58
$0.510.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.97% | 21.57% | 5.95% | -17.36% | 4.56% |
| Total Receivables | 23.82% | 16.01% | 4.23% | 35.82% | 13.28% |
| Inventory | 13.23% | 12.03% | 11.33% | 14.26% | 21.33% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.45% | 11.18% | 42.54% | -24.71% | -17.05% |
| Total Current Assets | 16.74% | 16.18% | 9.35% | 3.43% | 10.49% |
|
|
|||||
| Total Current Assets | 16.74% | 16.18% | 9.35% | 3.43% | 10.49% |
| Net Property, Plant & Equipment | -2.14% | -2.62% | -3.18% | -2.04% | -1.35% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -9.76% | -11.55% | 0.64% | -13.74% | -14.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.06% | -1.36% | -0.07% | 2.71% | 5.29% |
| Total Assets | 5.51% | 3.99% | 2.15% | 1.38% | 7.68% |
|
|
|||||
| Total Accounts Payable | 20.74% | 0.52% | -25.39% | 3.63% | -7.39% |
| Total Accrued Expenses | 8.09% | 6.30% | 6.33% | 20.16% | 19.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -98.48% | -98.75% | -98.49% | -98.40% | 5,995.08% |
| Total Finance Division Other Current Liabilities | 111.33% | 58.57% | -30.80% | -32.95% | -58.43% |
| Total Other Current Liabilities | 111.33% | 58.57% | -30.80% | -32.95% | -58.43% |
| Total Current Liabilities | -35.89% | -42.25% | -48.43% | -38.48% | 78.71% |
|
|
|||||
| Total Current Liabilities | -35.89% | -42.25% | -48.43% | -38.48% | 78.71% |
| Long-Term Debt | 0.34% | 0.34% | 0.34% | 0.34% | -45.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -18.01% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.67% | 10.51% | 19.26% | 20.92% | 21.66% |
| Total Liabilities | -19.74% | -24.76% | -29.58% | -22.75% | 0.03% |
|
|
|||||
| Common Stock & APIC | 2.72% | 3.11% | 3.39% | 3.56% | 3.69% |
| Retained Earnings | 154.38% | 98.31% | 68.68% | 50.21% | 37.61% |
| Treasury Stock & Other | -471.80% | 162.56% | 230.48% | -70.87% | 152.14% |
| Total Common Equity | 14.01% | 14.18% | 14.27% | 10.55% | 10.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.01% | 14.18% | 14.27% | 10.55% | 10.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.01% | 14.18% | 14.27% | 10.55% | 10.53% |
|
|
|||||